Patient preferences in choosing anti-TNF therapies-R1
Authors:
- E. L. WilliamsEWE. L. Williams
- C. J. EdwardsCEC. J. Edwards
Open Access
- 18 August 2006
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (12) , 1575-1576
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Severe keratopathy in paediatric Cogan's syndromeRheumatology, 2006
- Patient preferences in choosing anti-TNF therapies-R1Rheumatology, 2006
- Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritisAnnals of the Rheumatic Diseases, 2005
- Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinibBlood, 2005
- BSR guidelines on standards of care for persons with rheumatoid arthritisRheumatology, 2005
- Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemiaBlood, 2004
- Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemiaClinical Rheumatology, 2003
- Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory casesAnnals of Medicine, 2003
- The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of SpondylarthropathyArthritis & Rheumatism, 1991
- Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1987